___

Get­ting kids out­side and active could help with brain health: Par­tic­i­paction report (The Globe and Mail):

“The phys­i­cal ben­e­fits of kids lead­ing an active lifestyle, includ­ing bet­ter heart health and a decreased risk of devel­op­ing Type 2 dia­betes, are well known. But a grow­ing body of research sug­gests there are sig­nif­i­cant men­tal ben­e­fits as well, whether it’s low­er­ing stress lev­els or help­ing to treat anx­i­ety and depres­sion. A new report released by Par­tic­i­paction on Tues­day draws atten­tion to this link, Read the rest of this entry »

We hope you enjoy this slid­edeck sup­port­ing great for­ward-look­ing ideas shared by pio­neers at Mind­strong Health, Savonix, HealthTech Con­nex and Neu­raMetrix dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 5–7th, 2017).

And please learn more and con­sid­er reserv­ing your spot @ 2018 Sharp­Brains Vir­tu­al Sum­mit: Invest­ing in Brain Health for All (Decem­ber 4–6th, 2018).

___

A great way to learn more about our brains and minds is to look at how we can trick them–that is, to see how we react to brain teasers and visu­al illu­sions.

Below are four fun opti­cal illu­sions that let us learn­ about our visu­al system…ready?

(answers and expla­na­tions at the bot­tom)

___

Read the rest of this entry »

___

Many Amer­i­cans tak­ing com­mon meds that may cause depres­sion, study finds (CBS News):

“More than one-third of U.S. adults are tak­ing pre­scrip­tion med­ica­tions that may lead to depres­sion, new research finds. The study, pub­lished in the Jour­nal of the Amer­i­can Med­ical Asso­ci­a­tion, warns that depres­sion is a poten­tial side effect of more than 200 com­mon­ly pre­scribed med­ica­tions, Read the rest of this entry »

___

Mind­Maze Con­sol­i­dates First-ever FDA Approval for Inpa­tient and Out­pa­tient Neu­rore­ha­bil­i­ta­tion Ther­a­py (press release):

“Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States. Togeth­er with Mind­Mo­tion PRO (which received FDA clear­ance in 2017), Mind­Mo­tion GO is the next offer­ing in the company’s con­tin­u­um of care, pro­vid­ing gam­i­fied neu­rore­ha­bil­i­ta­tion ther­a­py. Read the rest of this entry »